Pubblicazioni

The homestasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients.  (2011)

Autori:
Fattovich, Giovanna; Covolo, L; Pasino, Michela; Perini, E; Rossi, L; Brocco, Giorgio; Guido, M; Cristofori, C; Belotti, C; Puoti, M; Gaeta, Gb; Santantonio, T; Raimondo, G; Bruno, R; Minola, E; Negro, F; Donato, F; Italian Hepatitis C., Cohort Study Collaborative Group
Titolo:
The homestasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients.
Anno:
2011
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
A Stampa
Referee:
Nome rivista:
LIVER INTERNATIONAL
ISSN Rivista:
1478-3223
N° Volume:
31
Numero o Fascicolo:
1
Intervallo pagine:
66-74
Parole chiave:
insulin resistance; hepatitis C; antiviral therapy
Breve descrizione dei contenuti:
OBJECTIVES: To investigate the independent association between the homeostasis model assessment of the insulin resistance (HOMA-IR) score and rapid virological response (RVR) and sustained virological response (SVR) in chronic hepatitis C (CHC). METHODS: Observational prospective cohort study of 412 CHC patients [59% males; mean age 45 years; genotype 1 (44%), 2 (32%), 3 (19%) and 4 (5%)] treated with pegylated interferon α plus ribavirin. RESULTS: A HOMA-IR ≥2.0 was present in 49% and a metabolic syndrome in 4% of patients. By multivariate analysis, independent predictors of SVR were the lack of advanced fibrosis (≥F3) in genotype 1 and a lower body mass index in genotype 3 patients. In the subgroup of patients in whom HCV-RNA was evaluated at week 4 (n = 281), independent predictors of RVR were HCV-RNA <700,000 IU/ml, age <40 years and lower aspartate aminotransferase:alanine aminotransferase ratio in genotype 1 and baseline HOMA-IR ≤2 in genotype 3 patients. No predictive factor of RVR was identified among genotype 2 patients. RVR was the strongest predictor of SVR among genotype 1 or 3 patients. CONCLUSIONS: In this series of treatment-naïve, Caucasian CHC patients at a low risk for the metabolic syndrome, HOMA-IR is not a predictor of SVR, irrespective of the HCV genotype, although it may predict RVR in genotype 3 infection.
Note:
Comment in Insulin resistance and sustained virological response in hepatitis C: from bench to bedside. [Liver Int. 2011]
Id prodotto:
59048
Handle IRIS:
11562/346055
depositato il:
10 febbraio 2011
ultima modifica:
15 novembre 2022
Citazione bibliografica:
Fattovich, Giovanna; Covolo, L; Pasino, Michela; Perini, E; Rossi, L; Brocco, Giorgio; Guido, M; Cristofori, C; Belotti, C; Puoti, M; Gaeta, Gb; Santantonio, T; Raimondo, G; Bruno, R; Minola, E; Negro, F; Donato, F; Italian Hepatitis C., Cohort Study Collaborative Group, The homestasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients. «LIVER INTERNATIONAL» , vol. 31 , n. 12011pp. 66-74

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

Progetti Collegati
Titolo Dipartimento Responsabili
Studio osservazionale multicentrico per la valutazione dei fattori che influenzano efficacia, tolleranza ed adesione al trattamento con interferone peghilato e ribavirina dei pazienti con epatite cronica da HCV nella pratica clinica corrente. Dipartimento Medicina Giovanna Fattovich
<<indietro

Attività

Strutture

Condividi